Whittier Trust Co. Buys 501 Shares of Axon Enterprise, Inc $AXON

Key Points

• Whittier Trust Co. increased its stake in Axon Enterprise, Inc by 2.5% in Q2, owning a total of 20,400 shares worth approximately $16.89 million.
• Axon reported $2.12 earnings per share for its last quarter, exceeding estimates of $1.54, with revenues rising by 32.6% year-over-year.
• Insider sales included Jeffrey C. Kunins selling 7,891 shares and CEO Patrick W. Smith selling 10,000 shares, indicating some changes in ownership stakes among executives.

Whittier Trust Co. grew its stake in shares of Axon Enterprise, Inc (NASDAQ:AXON - Free Report) by 2.5% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 20,400 shares of the biotechnology company's stock after purchasing an additional 501 shares during the period. Whittier Trust Co.'s holdings in Axon Enterprise were worth $16,890,000 as of its most recent SEC filing.

A number of other large investors have also recently modified their holdings of AXON. TCTC Holdings LLC boosted its stake in shares of Axon Enterprise by 75.0% during the 1st quarter. TCTC Holdings LLC now owns 56 shares of the biotechnology company's stock valued at $29,000 after purchasing an additional 24 shares in the last quarter. Bartlett & CO. Wealth Management LLC boosted its stake in shares of Axon Enterprise by 132.0% during the 1st quarter. Bartlett & CO. Wealth Management LLC now owns 58 shares of the biotechnology company's stock valued at $31,000 after purchasing an additional 33 shares in the last quarter. Banque Transatlantique SA purchased a new position in Axon Enterprise during the 1st quarter valued at about $31,000. Catalyst Capital Advisors LLC purchased a new position in Axon Enterprise during the 1st quarter valued at about $32,000. Finally, Flaharty Asset Management LLC purchased a new position in Axon Enterprise during the 1st quarter valued at about $33,000. Institutional investors own 79.08% of the company's stock.

Axon Enterprise Stock Up 1.9%

AXON stock opened at $683.13 on Tuesday. Axon Enterprise, Inc has a 1-year low of $422.38 and a 1-year high of $885.91. The business has a fifty day moving average price of $736.73 and a 200-day moving average price of $720.91. The company has a debt-to-equity ratio of 0.63, a current ratio of 2.95 and a quick ratio of 2.71. The stock has a market capitalization of $53.63 billion, a P/E ratio of 168.67, a P/E/G ratio of 26.04 and a beta of 1.41.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The biotechnology company reported $2.12 earnings per share for the quarter, topping the consensus estimate of $1.54 by $0.58. Axon Enterprise had a return on equity of 6.80% and a net margin of 13.64%.The firm had revenue of $668.54 million during the quarter, compared to analysts' expectations of $641.77 million. During the same quarter in the previous year, the business earned $1.20 earnings per share. The company's revenue was up 32.6% on a year-over-year basis. Axon Enterprise has set its FY 2025 guidance at EPS. Equities analysts forecast that Axon Enterprise, Inc will post 5.8 earnings per share for the current fiscal year.

Insider Activity

In other news, insider Jeffrey C. Kunins sold 7,891 shares of the business's stock in a transaction that occurred on Thursday, August 14th. The shares were sold at an average price of $750.10, for a total transaction of $5,919,039.10. Following the completion of the transaction, the insider directly owned 144,538 shares of the company's stock, valued at $108,417,953.80. The trade was a 5.18% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Patrick W. Smith sold 10,000 shares of the business's stock in a transaction that occurred on Monday, August 11th. The shares were sold at an average price of $831.29, for a total transaction of $8,312,900.00. Following the transaction, the chief executive officer directly owned 3,053,982 shares of the company's stock, valued at $2,538,744,696.78. The trade was a 0.33% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 59,932 shares of company stock valued at $45,115,616 over the last three months. Corporate insiders own 5.70% of the company's stock.

Analysts Set New Price Targets

AXON has been the subject of a number of recent research reports. Piper Sandler initiated coverage on shares of Axon Enterprise in a research report on Tuesday, September 23rd. They set an "overweight" rating and a $893.00 price target for the company. Wolfe Research initiated coverage on shares of Axon Enterprise in a research report on Monday, July 7th. They set an "outperform" rating for the company. Morgan Stanley set a $885.00 price target on shares of Axon Enterprise and gave the company an "overweight" rating in a research report on Friday, July 11th. Needham & Company LLC reissued a "buy" rating and set a $870.00 price target on shares of Axon Enterprise in a research report on Wednesday, September 24th. Finally, Weiss Ratings reissued a "hold (c)" rating on shares of Axon Enterprise in a research report on Wednesday, October 8th. Fourteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. Based on data from MarketBeat.com, Axon Enterprise presently has an average rating of "Moderate Buy" and a consensus price target of $841.64.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.

Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc (NASDAQ:AXON - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.